Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


04.03.2024

1 Acta Haematol
3 Am J Hematol
3 Ann Hematol
3 Blood
1 Cancer Chemother Pharmacol
1 Cancer Res
2 Int J Hematol
3 J Pediatr Hematol Oncol
4 Leuk Lymphoma
2 Leuk Res
5 Leukemia
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. PARIGGER T, Drothler S, Scherhaufl C, Gassner FJ, et al
    Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic Leukemia patient with Richter Transformation: A Case Report and Review of the Literature.
    Acta Haematol. 2024 Feb 24. doi: 10.1159/000537791.
    PubMed         Abstract available


    Am J Hematol

  2. MIRVIS E, Sairam S, Vainieri E, Tona F, et al
    Pituitary apoplexy in acute promyelocytic leukemia.
    Am J Hematol. 2024 Feb 29. doi: 10.1002/ajh.27277.
    PubMed        

  3. JIANG M, Wang X, Yu M, Jiang S, et al
    Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
    Am J Hematol. 2024 Feb 27. doi: 10.1002/ajh.27272.
    PubMed         Abstract available

  4. SANDBERG Y, Budel LM, Bain BJ
    Neutrophilic leukemoid reaction or chronic neutrophilic leukemia-not always so simple.
    Am J Hematol. 2024 Feb 23. doi: 10.1002/ajh.27268.
    PubMed        


    Ann Hematol

  5. PALANI HK, Ganesan S, Balasundaram N, Venkatraman A, et al
    Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia.
    Ann Hematol. 2024 Mar 1. doi: 10.1007/s00277-024-05673.
    PubMed        

  6. SCHWANER I, Kuhn T, Losem C, Wolff T, et al
    Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
    Ann Hematol. 2024 Feb 29. doi: 10.1007/s00277-024-05638.
    PubMed         Abstract available

  7. CHEN Y, Zheng J, Weng Y, Wu Z, et al
    Myelodysplasia-related gene mutations are associated with favorable prognosis in patients with TP53-mutant acute myeloid leukemia.
    Ann Hematol. 2024 Feb 27. doi: 10.1007/s00277-024-05679.
    PubMed         Abstract available


    Blood

  8. MURTADHA M, Park M, Zhu Y, Caserta E, et al
    CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNgamma-induced CD38 expression.
    Blood. 2024 Feb 26:blood.2023021570. doi: 10.1182/blood.2023021570.
    PubMed         Abstract available

  9. VAN OUTERSTERP I, Tasian SK, Reichert CE, Boeree A, et al
    Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The role of kinase type and SH3 domain.
    Blood. 2024 Feb 23:blood.2023023120. doi: 10.1182/blood.2023023120.
    PubMed         Abstract available

  10. BISWAS J, Abdel-Wahab O
    A new SAGA for AML: targeting SGF29 in AML.
    Blood. 2024;143:657-658.
    PubMed        


    Cancer Chemother Pharmacol

  11. MARCELLETTI JF, Sikic BI
    Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.
    Cancer Chemother Pharmacol. 2024 Feb 26. doi: 10.1007/s00280-024-04656.
    PubMed         Abstract available


    Cancer Res

  12. JIN P, Wang X, Jin Q, Zhang Y, et al
    Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to chemotherapy in acute myeloid leukemia.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-2543.
    PubMed         Abstract available


    Int J Hematol

  13. SHIOZAWA Y, Fujita S, Nannya Y, Ogawa S, et al
    First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
    Int J Hematol. 2024 Feb 29. doi: 10.1007/s12185-024-03724.
    PubMed         Abstract available

  14. CHOED-AMPHAI C, Khorana J, Sathitsamitphong L, Natesirinilkul R, et al
    Predictive factors for L-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2024 Feb 29. doi: 10.1007/s12185-024-03725.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  15. HOSHINO Y, Moriya K, Mitsui-Sekinaka K, Hashimoto Y, et al
    Noonan Syndrome-related Myeloproliferative Disorder Occurring in the Neonatal Period: Case Report and Literature Review.
    J Pediatr Hematol Oncol. 2024;46:e176-e179.
    PubMed         Abstract available

  16. WOLFSET N, Pashmineh Azar AR, Phillips CA, Stein M, et al
    Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
    J Pediatr Hematol Oncol. 2024;46:e202-e204.
    PubMed         Abstract available

  17. JIANG MR, Ahmet A, Lawrence S, Bassal M, et al
    Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series.
    J Pediatr Hematol Oncol. 2024;46:e121-e126.
    PubMed         Abstract available


    Leuk Lymphoma

  18. NASKAR S, Paul T, Kulkarni JD, Anand KC, et al
    TCF3::PBX1 fusion pediatric B acute lymphoblastic leukemia in disguise behind the eyes - an unusual clinicopathologic presentation with hyperdiploid clone.
    Leuk Lymphoma. 2024 Feb 26:1-5. doi: 10.1080/10428194.2024.2320827.
    PubMed        

  19. STEIN EM, Fathi AT, Harb WA, Colak G, et al
    Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies.
    Leuk Lymphoma. 2024;65:503-510.
    PubMed         Abstract available

  20. PARVIZ M, Agius R, Rotbain EC, Vainer N, et al
    Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning.
    Leuk Lymphoma. 2024;65:449-459.
    PubMed         Abstract available

  21. ALDOSS I, Clark MC, Wang X, Forman SJ, et al
    Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?
    Leuk Lymphoma. 2024;65:440-448.
    PubMed         Abstract available


    Leuk Res

  22. ELGHETANY MT, Patnaik MM, Khoury JD
    Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
    Leuk Res. 2024;137:107441.
    PubMed         Abstract available

  23. RAMOS-CILLAN S, Lainez-Gonzalez D, Solan L, Blas C, et al
    When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML.
    Leuk Res. 2024;137:107440.
    PubMed        


    Leukemia

  24. CLAUDIANI S, Chughtai F, Khan A, Hayden C, et al
    Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance.
    Leukemia. 2024 Feb 29. doi: 10.1038/s41375-024-02187.
    PubMed         Abstract available

  25. YANG X, Liu J, Liu W, Wu H, et al
    circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
    Leukemia. 2024 Feb 29. doi: 10.1038/s41375-024-02189.
    PubMed         Abstract available

  26. FLYGT H, Soderlund S, Richter J, Saussele S, et al
    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
    Leukemia. 2024 Feb 28. doi: 10.1038/s41375-024-02184.
    PubMed        

  27. MONTALBAN-BRAVO G, Rodriguez-Sevilla JJ, Swanson DM, Kanagal-Shamanna R, et al
    Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia.
    Leukemia. 2024 Feb 28. doi: 10.1038/s41375-024-02190.
    PubMed        

  28. JUNK SV, Forster A, Schmidt G, Zimmermann M, et al
    Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study.
    Leukemia. 2024 Feb 27. doi: 10.1038/s41375-024-02173.
    PubMed        


    Proc Natl Acad Sci U S A

  29. LI JF, Cheng WY, Lin XJ, Wen LJ, et al
    Aging and comprehensive molecular profiling in acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2024;121:e2319366121.
    PubMed         Abstract available

  30. ROSELLE C, Horikawa I, Chen L, Kelly AR, et al
    Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Delta133p53alpha.
    Proc Natl Acad Sci U S A. 2024;121:e2317735121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.